Join
Live feed
·
INSIDERFilingvia Quantisnow
Rocket Pharmaceuticals Inc. logo

CEO Shah Gaurav sold $19,995 worth of shares (5,990 units at $3.34), decreasing direct ownership by 0.57% to 1,046,055 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RCKT· Rocket Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RCKT (Rocket Pharmaceuticals Inc.) and more on Quantisnow.